2004S-0233 - Solicitation of Comments on Stimulating Innovation in Medical Technologies
FDA Comment Number : EC13
Submitter : Mr. Blair Childs Date & Time: 09/14/2004 06:09:05
Organization : Value Group
Health Care Association
Category :
Issue Areas/Comments
GENERAL
GENERAL
See Attachment
Questions
1. What strategies and approaches could HHS implement to accelerate the development and application of new medical technologies?
See Attachment
2. How can HHS help its agencies (e.g., NIH (and its grantees), FDA, CDC, and CMS) to work together more effectively to eliminate obstacles to development of medical technologies?
See Attachment
3. How can the HHS scientific and regulatory agencies work more effectively with CMS to eliminate obstacles to development?
See Attachment
4. What forums should HHS use to survey constituents about obstacles in innovation (e.g., public meetings, contract research, focus groups)?
See Attachment
5. How can the portability of informaion between HHS agencies be optimized?
See Attachment
6. Which HHS policies and programs effectively spur innovation?
See Attachment